Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released Aug 8, 2016, before the open
10-Q filed Aug 8, 2016, 39 days after period end · 0001564590-16-023141
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Net Income | -$18.88M | -$14.95M | -$4.51M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 8, 2016 · 39 d after period end
9.4% from the close of Aug 5, 2016 to the close of Aug 8, 2016, the first after the release.